Model
Edge
Cero Therapeutics Holdings, Inc.
PBAX
Filing Type
8-K
Filing Date
12/18/2025
Updated
12/19/25, 2:49 PM
Filing
8-K
Earnings Release
Exhibits
8-K
Changes in Board, Management or Compensation, Shareholder votes
EX-10.1
FOURTH AMENDMENT TO THE CERO THERAPEUTICS HOLDINGS, INC. 2024 EQUITY INCENTIVE PLAN